Dexcom Hit With Atty Fees For 'Bad Faith' Patent Suit

Law360 (May 23, 2018, 10:16 PM EDT) -- Diabetes glucose monitoring company Dexcom Inc. has to pay attorneys’ fees to its New Hampshire-based rival after a California federal judge held that it acted in “bad faith” by continuing to litigate a patent case despite multiple court warnings, according to an order unsealed Tuesday.

San Diego-based Dexcom no longer had a viable patent suit against AgaMatrix Inc. after the court issued a claim construction order in August 2017, but the company pressed on anyway despite “repeated admonishments” that attorneys’ fees could be granted if the case were deemed “exceptional” for being weak or baseless, according to U.S. District Judge S....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS